STOCK TITAN

Cencora Stock Price, News & Analysis

COR NYSE

Company Description

About Cencora Inc. (Symbol: COR)

Cencora Inc., formerly known as AmerisourceBergen, stands as a pivotal player in the global healthcare supply chain, specializing in pharmaceutical distribution and related services. Operating at the intersection of healthcare delivery and supply chain logistics, Cencora ensures the efficient and secure distribution of branded, generic, and specialty pharmaceuticals, as well as over-the-counter (OTC) healthcare products. Its services are integral to pharmacies, hospital networks, healthcare providers, and pharmaceutical manufacturers, making it a cornerstone of the healthcare ecosystem.

Core Business Operations

Cencora’s business model is built around three primary pillars:

  • Pharmaceutical Distribution: Cencora sources and distributes a wide range of pharmaceutical products to retail pharmacies (chains and independents), mail-order pharmacies, and healthcare providers. Its streamlined operations enhance product accessibility, cost-efficiency, and supply chain reliability.
  • Commercialization and Manufacturer Services: The company offers end-to-end solutions for pharmaceutical and medical device manufacturers, maximizing product success throughout the lifecycle. These services include market access strategies, regulatory support, and commercialization solutions.
  • Specialty Logistics and Animal Health: Through its World Courier division, Cencora provides global specialty drug logistics, ensuring the secure and timely delivery of high-value, temperature-sensitive pharmaceuticals. Additionally, its MWI Animal Health segment focuses on the distribution of animal health products, catering to veterinary practices and agricultural businesses.

Global Reach and Strategic Expansion

While Cencora is a dominant player in the U.S. pharmaceutical wholesale market, alongside competitors McKesson and Cardinal Health, it has significantly expanded its international footprint. In 2021, the acquisition of Alliance Healthcare, a leading drug wholesaler in Europe, marked a strategic move to strengthen its global presence. This expansion positions Cencora as a key player in both domestic and international markets, enabling it to leverage economies of scale and enhance its service offerings.

Value Proposition

Cencora’s value proposition lies in its ability to streamline the healthcare supply chain, ensuring that medications and healthcare products are delivered securely, consistently, and cost-effectively. By improving product access for pharmacies, providers, and patients, the company plays a critical role in enhancing healthcare delivery. Additionally, its tailored solutions for manufacturers and providers drive operational efficiency, cost control, and patient safety, further solidifying its importance in the industry.

Competitive Positioning

As one of the “Big Three” pharmaceutical wholesalers in the U.S., Cencora holds a significant market share, alongside McKesson and Cardinal Health. Together, these three companies account for over 90% of the U.S. pharmaceutical wholesale market. Cencora differentiates itself through its specialized services, such as global logistics via World Courier and its focus on animal health through MWI Animal Health. Its strategic acquisitions and commitment to innovation further bolster its competitive edge.

Industry Significance

The pharmaceutical wholesale industry is a critical component of the healthcare system, ensuring the timely and efficient distribution of life-saving medications. Cencora’s role in this ecosystem extends beyond distribution; its comprehensive service offerings address the complexities of pharmaceutical commercialization, logistics, and supply chain management. By bridging the gap between manufacturers and end-users, Cencora contributes to improved healthcare outcomes worldwide.

Conclusion

Cencora Inc. exemplifies the integration of expertise, innovation, and operational excellence in the healthcare supply chain. Its diverse business segments, strategic global expansion, and focus on enhancing healthcare delivery position it as a trusted partner for stakeholders across the healthcare spectrum. As the healthcare landscape continues to evolve, Cencora’s role in shaping efficient and effective delivery systems remains indispensable.

Stock Performance

$—
0.00%
0.00
Last updated:
7.74 %
Performance 1 year
$55.5B
Market Cap
193.7M
Shares outstanding

SEC Filings

No SEC filings available for Cencora.

Financial Highlights

$81,487,060,000
Revenue (TTM)
$493,719,000
Net Income (TTM)
$2.50
Diluted EPS (TTM)
-$2,718,782,000
Operating Cash Flow
0.61%
Net Profit Margin
0.87%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Cencora (COR)?

The current stock price of Cencora (COR) is $285.9 as of April 25, 2025.

What is the market cap of Cencora (COR)?

The market cap of Cencora (COR) is approximately 55.5B.

What is the revenue (TTM) of Cencora (COR) stock?

The trailing twelve months (TTM) revenue of Cencora (COR) is $81,487,060,000.

What is the net income of Cencora (COR)?

The trailing twelve months (TTM) net income of Cencora (COR) is $493,719,000.

What is the earnings per share (EPS) of Cencora (COR)?

The diluted earnings per share (EPS) of Cencora (COR) is $2.50 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Cencora (COR)?

The operating cash flow of Cencora (COR) is -$2,718,782,000.

What is the profit margin of Cencora (COR)?

The net profit margin of Cencora (COR) is 0.61%.

What is the operating margin of Cencora (COR)?

The operating profit margin of Cencora (COR) is 0.87%.

What is the gross margin of Cencora (COR)?

The gross profit margin of Cencora (COR) is 3.14%.

What is the current ratio of Cencora (COR)?

The current ratio of Cencora (COR) is 0.92, indicating the company's ability to pay short-term obligations.

What is the gross profit of Cencora (COR)?

The gross profit of Cencora (COR) is $2,558,038,000 on a trailing twelve months (TTM) basis.

What is the operating income of Cencora (COR)?

The operating income of Cencora (COR) is $706,254,000.

What does Cencora Inc. do?

Cencora Inc. specializes in pharmaceutical distribution, supply chain solutions, and related services, supporting pharmacies, healthcare providers, and manufacturers.

How does Cencora generate revenue?

Cencora generates revenue through pharmaceutical distribution, commercialization services for manufacturers, global logistics, and animal health product distribution.

What is Cencora's competitive position in the industry?

Cencora is one of the top three pharmaceutical wholesalers in the U.S., alongside McKesson and Cardinal Health, collectively dominating over 90% of the market.

What industries does Cencora serve?

Cencora serves the pharmaceutical, healthcare, and animal health industries, providing distribution, logistics, and commercialization solutions.

What are Cencora's key business segments?

Cencora's key business segments include pharmaceutical distribution, manufacturer services, specialty logistics (World Courier), and animal health (MWI Animal Health).

How has Cencora expanded internationally?

Cencora expanded its global presence by acquiring Alliance Healthcare in 2021, a leading European drug wholesaler, to strengthen its international operations.

What is Cencora's role in the healthcare supply chain?

Cencora ensures the efficient, secure, and cost-effective distribution of pharmaceuticals, enhancing product access for pharmacies, providers, and patients.

What is World Courier, and how is it related to Cencora?

World Courier is a division of Cencora specializing in global specialty drug logistics, ensuring the secure delivery of high-value, temperature-sensitive pharmaceuticals.

What is MWI Animal Health, and what does it do?

MWI Animal Health, a division of Cencora, focuses on the distribution of animal health products, serving veterinary practices and agricultural businesses.

How does Cencora support pharmaceutical manufacturers?

Cencora provides end-to-end commercialization solutions for manufacturers, including market access strategies, regulatory support, and product lifecycle management.